Thursday, September 18, 2014 9:43:56 PM
Merriman Capital Initiates on True Drinks Holdings, Inc. with a Buy Rating
Merriman Holdings Inc. June 11, 2014 10:03 AM GlobeNewswire Europe
View photo
.
SAN FRANCISCO - June 11, 2014 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (MERR), announced that it has initiated equity research coverage of True Drinks Holdings, Inc. (TRUU) with a Buy rating and a $2.20 price target.
True Drinks develops and markets healthy beverages such as naturally flavored water and energy drinks. The Company`s flagship product, AquaBallTM Naturally Flavored Water, is sugar-free, calorie-free and does not contain harmful sweeteners. AquaBall is a healthy hydration alternative to high sugar drinks for children, and the Company has licensing agreements with Disney and Marvel and distribution to over 28,500 stores nationwide. The current management team brings significant international food and beverage distribution experience. True Drinks was founded in 2008 and is headquartered in Irvine, CA.
True Drinks operates the majority of its sales, R&D and corporate infrastructure through its headquarters in Irvine, California and manufactures the majority of its products at three packing/manufacturing facilities located in New York, California and Texas. TRUU went public through a reverse merger in October of 2012. Since its inception, TRUU has established a distribution presence that encompasses over 26,000 retail storefronts with leading chains such as Albertsons, Kroger, Winn Dixie, H-E-B, Bristol Farms, Gelson`s, WinCo, Sam`s Club and Rite Aid. The company has also forged exclusive branding partnerships with Disney and Marvel, which provide TRUU with a unique marketing opportunity that should ultimately augment customer acquisition rates. TRUU generates revenue through the sale of its AquaBall line to brick-and-mortar retailers and direct-to-consumer sales of AquaBall and Bazi over the internet.
Recent CHUC News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:30:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:27:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 10:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 09:56:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 09:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 09:53:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 09:51:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 09:43:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 09:41:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:15:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:05:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 02:54:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM